narasin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
5583 55134-13-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • narasin
  • C-7819B
  • compound 79891
  • monteban
  • Molecular weight: 765.04
  • Formula: C43H72O11
  • CLOGP: 6.89
  • LIPINSKI: 3
  • HAC: 11
  • HDO: 4
  • TPSA: 161.21
  • ALOGS: -5.50
  • ROTB: 12

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000900 Anti-Bacterial Agents
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000977 Antiparasitic Agents
MeSH PA D000981 Antiprotozoal Agents
MeSH PA D003049 Coccidiostats

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

SpeciesUseRelation
Chickens Prevention of coccidiosis caused by Eimeria necatrix Indication
Chickens Prevention of coccidiosis caused by Eimeria tenella Indication
Chickens Prevention of coccidiosis caused by E acervulina Indication
Chickens Prevention of coccidiosis caused by E brunetti Indication
Chickens Prevention of coccidiosis caused by E mivati Indication
Chickens Prevention of coccidiosis caused by E maxima Indication
Swine To increase rate of weight gain Indication

🐶 Veterinary products

ProductApplicantIngredients
Monteban 45 Elanco US Inc. 1
Maxiban 72 Elanco US Inc. 2
Flavomycin / Monteban Huvepharma EOOD 2
BMD / Monteban Zoetis Inc. 2
Baciferm / Albac, Baciferm / Monteban Zoetis Inc. 2
BMD / Maxiban Elanco US Inc. 3
Flavomycin / Maxiban Elanco US Inc. 3
BMD / Maxiban Zoetis Inc. 3
Skycis 100 Elanco US Inc. 1
Inteprity and Maxiban Elanco US Inc. 3
Inteprity and Monteban Elanco US Inc. 2
Pennitracin MD and Maxiban Pharmgate Inc. 3

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEMBL2104423 ChEMBL_ID
C013612 MESH_SUPPLEMENTAL_RECORD_UI
10835 IUPHAR_LIGAND_ID
DB11432 DRUGBANK_ID
C0068443 UMLSCUI
3935 INN_ID
96162001 SNOMEDCT_US
D05122 KEGG_DRUG
65452 PUBCHEM_CID
1314370 RXNORM
DZY9VU539P UNII

Pharmaceutical products:

None